PAGE 1
WES MOORE, Governor Ch. 253

Chapter 253

(House Bill 283)

AN ACT concerning

Maryland Medical Assistance Program – Gender–Affirming Treatment
(Trans Health Equity Act)

FOR the purpose of requiring, beginning on a certain date, the Maryland Medical
Assistance Program to provide medically necessary gender–affirming treatment in a
nondiscriminatory manner; requiring that the gender–affirming treatment be
assessed according to nondiscriminatory criteria that are consistent with current
clinical standards; prohibiting the Program from issuing an adverse benefit
determination related to gender–affirming treatment unless a health care provider
with experience prescribing or delivering gender–affirming treatment has reviewed
and confirmed the appropriateness of the determination; and generally relating to
gender–affirming treatment and the Maryland Medical Assistance Program.

BY repealing and reenacting, without amendments,
Article – Health – General
Section 15–103(a)(1)
Annotated Code of Maryland
(2019 Replacement Volume and 2022 Supplement)

BY repealing and reenacting, with amendments,
Article – Health – General
Section 15–103(a)(2)(xx) and (xxi)
Annotated Code of Maryland
(2019 Replacement Volume and 2022 Supplement)

BY adding to
Article – Health – General
Section 15–103(a)(2)(xxii) and 15–151
Annotated Code of Maryland
(2019 Replacement Volume and 2022 Supplement)

SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
That the Laws of Maryland read as follows:

Article – Health – General

15–103.

(a) (1) The Secretary shall administer the Maryland Medical Assistance
Program.

– 1 –

PAGE 2
Ch. 253 2023 LAWS OF MARYLAND

(2) The Program:

(xx) Beginning on July 1, 2023, shall provide, subject to federal
approval and limitations of the State budget, community violence prevention services in
[and]accordance with 15–141.3 of this subtitle;

(xxi) Beginning on January 1, 2023, shall provide, subject to the
limitations of the State budget, and as permitted by federal law, coverage for self–measured
blood pressure monitoring for all Program recipients diagnosed with uncontrolled high
blood pressure, including:

1. The provision of validated home blood pressure monitors;
and

2. Reimbursement of health care provider and other staff
time used for patient training, transmission of blood pressure data, interpretation of blood
pressure readings and reporting, and the delivery of co–interventions, including
educational materials or classes, behavioral change management, and medication
management; AND

(XXII)BEGINNING JANUARY 1, 2024,ON SHALL PROVIDE
GENDER–AFFIRMING § 15–151TREATMENT IN ACCORDANCE WITH OF THIS
SUBTITLE.

15–151.

(A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS
INDICATED.

(2) (I) “GENDER–AFFIRMING TREATMENT” MEANS ANY
MEDICALLY NECESSARY TREATMENT CONSISTENT WITH CURRENT CLINICAL
STANDARDS OF CARE PRESCRIBED BY A LICENSED HEALTH CARE PROVIDER FOR
INDIVIDUAL’STHE TREATMENT OF A CONDITION RELATED TO THE GENDER
IDENTITY.

(II) “GENDER–AFFIRMING TREATMENT” INCLUDES:

1. HORMONE THERAPY, BLOCKERS,HORMONE AND
BLOCKERS;PUBERTY

2. HAIR ALTERATION FOR THE PURPOSES OF ALTERING
PREPARATION;SECONDARY SEX CHARACTERISTICS AND SURGICAL SITE

– 2 –

PAGE 3
WES MOORE, Governor Ch. 253

3. ALTERATIONS VOICE, THERAPY,TO VOICE AND VOICE
LESSONS;

4. ALTERATIONS ABDOMEN, CHEST, TRUNK,TO AND
BUTTOCKS;

5. ALTERATIONS NECK;TO THE FACE AND

6. ALTERATIONS GONADS;TO THE GENITALS AND

7. LASER TREATMENT FOR SCARS FROM
GENDER–AFFIRMING TREATMENT;

8. STANDARD PROCEDURES,FERTILITY PRESERVATION
§ 15–810.1 INSURANCE ARTICLE;AS SET FORTH IN OF THE

9. REVISIONS TO PREVIOUS TREATMENTS AND
TREATMENTS;REVERSAL OF

10. COMBINATIONS GENDER–AFFIRMINGOF
PROCEDURES; AND

11. OTHER TREATMENTS AS PRESCRIBED TO SUPPRESS
CHARACTERISTICS,THE DEVELOPMENT OF ENDOGENOUS SECONDARY SEX ALIGN
INDIVIDUAL’S IDENTITY,THE APPEARANCE OR PHYSICAL BODY WITH GENDER AND
ALLEVIATE SYMPTOMS OF CLINICALLY SIGNIFICANT DISTRESS RESULTING FROM
DYSPHORIA.GENDER

(III) “GENDER–AFFIRMING TREATMENT” MAY INCLUDE
TREATMENT DESCRIBED IN THE CURRENT CLINICAL STANDARDS OF CARE FOR
GENDER–AFFIRMING WORLD PROFESSIONALTREATMENT PUBLISHED BY THE
ASSOCIATION TRANSGENDER HEALTH.FOR

(3) “GENDER IDENTITY” § 20–101HAS THE MEANING STATED IN OF
STATE GOVERNMENT ARTICLE.THE

(B) IT GENERAL ASSEMBLY PROGRAMIS THE INTENT OF THE THAT THE
GENDER–AFFIRMING PROGRAMPROVIDE TREATMENT TO ALL RECIPIENTS FOR
GENDER–AFFIRMING NECESSARY,WHOM TREATMENT IS MEDICALLY INCLUDING
TRANSGENDER, NONBINARY, INTERSEX, TWO–SPIRIT, AND OTHER GENDER DIVERSE
INDIVIDUALS.

(C) (1) THE PROGRAM SHALL PROVIDE COVERAGE FOR MEDICALLY
GENDER–AFFIRMING MANNER.NECESSARY TREATMENT IN A NONDISCRIMINATORY
– 3 –

PAGE 4
Ch. 253 2023 LAWS OF MARYLAND

(2) THE GENDER–AFFIRMING TREATMENT SHALL BE ASSESSED
ACCORDING TO NONDISCRIMINATORY CRITERIA THAT ARE CONSISTENT WITH
CARE.CURRENT CLINICAL STANDARDS OF

(3) THE PROGRAM MAY NOT DENY OR LIMIT COVERAGE FOR
GENDER–AFFIRMING IS:TREATMENT WHEN THAT TREATMENT

(I) PRESCRIBED PROGRAM OF,TO A RECIPIENT BECAUSE
TO, RECIPIENT’S IDENTITY;RELATED OR CONSISTENT WITH THE GENDER

(II) MEDICALLY NECESSARY; AND

(III) PRESCRIBED IN ACCORDANCE WITH CURRENT CLINICAL
CARE.STANDARDS OF

(4) THE PROGRAM MAY NOT DENY OR LIMIT COVERAGE FOR
GENDER–AFFIRMING PROGRAM RECIPIENT’STREATMENT BASED ON THE GENDER
IDENTITY.

(5) THE PROGRAM GENDER–AFFIRMINGMAY NOT EXCLUDE
TREATMENT, GENDER–AFFIRMING TREATMENT,INCLUDING REVISIONS TO PRIOR
SERVICE.ON THE BASIS THAT THE TREATMENT IS A COSMETIC

(6) THE PROGRAM MAY NOT ESTABLISH A CATEGORICAL EXCLUSION
GENDER–AFFIRMING TREATMENT.FOR A PARTICULAR

(7) THE PROGRAM MAY NOT ISSUE AN ADVERSE BENEFIT
GENDER–AFFIRMINGDETERMINATION DENYING OR LIMITING ACCESS TO
TREATMENT UNLESS A HEALTH CARE PROVIDER WITH EXPERIENCE PRESCRIBING
GENDER–AFFIRMINGOR DELIVERING TREATMENT HAS REVIEWED AND CONFIRMED
DETERMINATION.THE APPROPRIATENESS OF THE ADVERSE BENEFIT

(D) (1) ON DECEMBER 1 YEAR, 2024,OR BEFORE EACH BEGINNING IN
DEPARTMENTEACH MANAGED CARE ORGANIZATION SHALL SUBMIT TO THE A
INCLUDES,REPORT THAT FOR EACH HEALTH CARE PROVIDER OFFERING
GENDER–AFFIRMING TREATMENT WITH WHICH THE MANAGED CARE ORGANIZATION
INCLUSION:HAS AN ACTIVE CONTRACT AND ~~WHO~~ THAT CONSENTS TO THE

(I) THE NAME AND LOCATION OF ~~EACH~~ THE HEALTH CARE
~~GENDER–AFFIRMING~~PROVIDER ~~OFFERING~~ ~~TREATMENT~~ ~~WITH~~ ~~WHICH~~ ~~THE~~ ~~MANAGED~~
~~CONTRACT;~~~~CARE~~ ~~ORGANIZATION~~ ~~HAS~~ ~~AN~~ ~~ACTIVE~~ ~~AND~~

– 4 –

PAGE 5
WES MOORE, Governor Ch. 253

(II) THE GENDER–AFFIRMINGTYPES OF TREATMENT PROVIDED
PROVIDER;BY ~~EACH~~ THE HEALTH CARE AND

(III) WHETHER THE HEALTH CARE PROVIDER CONSENTS TO
DEPARTMENT’SBEING PUBLICLY LISTED AS PART OF THE ANNUAL REPORT
(2) SUBSECTION.REQUIRED UNDER PARAGRAPH OF THIS

(2) (I) ON JANUARY 1 YEAR,OR BEFORE EACH BEGINNING IN
2025, DEPARTMENTTHE SHALL COMPILE AN ANNUAL REPORT ON GEOGRAPHIC
GENDER–AFFIRMING STATE.ACCESS TO TREATMENT ACROSS THE

(II) THE INCLUDE,REPORT SHALL FOR EACH HEALTH CARE
GENDER–AFFIRMING PROGRAMPROVIDER OFFERING TREATMENT TO RECIPIENTS
AND WHOSE CONSENT TO THE INCLUSION IS INDICATED IN A REPORT SUBMITTED
(1) SUBSECTION:UNDER PARAGRAPH OF THIS

1. THE NAME AND LOCATION OF ~~EACH~~ THE HEALTH
~~GENDER–AFFIRMING~~ ~~PROGRAM~~CARE PROVIDER ~~OFFERING~~ ~~TREATMENT~~ ~~TO~~
~~RECIPIENTS;~~

2. THE MANAGED CARE ORGANIZATIONS THAT HAVE
PROVIDER;ACTIVE CONTRACTS WITH ~~EACH~~ THE HEALTH CARE AND

3. THE GENDER–AFFIRMINGTYPES OF TREATMENT
PROVIDER.PROVIDED BY ~~EACH~~ THE HEALTH CARE

(III) THE DEPARTMENT SHALL PUBLISH THE REPORT IN A
DEPARTMENT’S WEBSITE.CONSPICUOUS MANNER ON THE

(3) THE DEPARTMENT AND EACH MANAGED CARE ORGANIZATION
NAME, LOCATION,SHALL INCLUDE THE AND TYPES OF SERVICES FOR EACH
GENDER–AFFIRMINGPROVIDER OFFERING TREATMENT IN THEIR PROVIDER
DIRECTORIES.

SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
October 1, 2023.

Approved by the Governor, May 3, 2023.

– 5 –